WKHS Locations

Clinical Trials

  • GWCA0999

    This is a 6 month extension study to evaluate the safety of long-term Sativex® therapy when used as an adjunctive measure in patients with advanced cancer.

  • GWCA0962/GWCA0958 Cancer Pain

    This nine week study will aim to determine the efficacy, safety and tolerability of Sativex® as an adjunctive treatment, compared with placebo in relieving uncontrolled persistent chronic pain in patients with advance cancer.  

    o   Treat pain in patients with advanced cancer that experience inadequate pain relief with currently available medications or have side effects with currently available medications.

  • 13.0001 - Prophylactic Intervention on Bone Pain in Breast Cancer

    To compare the difference across cycles of bone pain between treatment groups in patients receiving chemotherapy and Neulasta